While emerging research explores potential anti-inflammatory properties of GLP-1 receptor agonists, tirzepatide has no FDA approval for autoimmune conditions such as rheumatoid arthritis, lupus, or inflammatory bowel disease
If you want good margins, your cost of goods sold for aesthetics treatments usually runs 10-40% of revenue per treatment, depending on what youre offering
Values range from about 8 to 30 minutes after intravenous or intramuscular dosing
Source: SetPoint Medical - #MedTech #Innovation #Healthcare #BioelectronicMedicine To view or add a comment, sign in We are pleased to share the publication of a new late-phase, real-world study evaluating Polmacoxib 2 mg in Indian patients with hip and knee osteoarthritis
Future research directions While reassuring data are accumulating about the safety profile of GLP-1 receptor agonists (GLP-1 RAs) used for diabetes and obesity management, there are still significant gaps in our understanding that justifies the need for well-designed multidisciplinary translational and clinical studies
